Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1163125 Target Snapshot

Bromodomain-containing protein 4 · SINGLE PROTEIN · Homo sapiens

15,192Compounds
3,563Assays
11Approved Drugs
23,472.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-12

Protein identity stays anchored to UniProt O60885. Use UniProt O60885 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O60885 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-12
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Bromodomain-containing protein 4 as ChEMBL target CHEMBL1163125, mapped to UniProt O60885. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Bromodomain-containing protein 4
SINGLE PROTEIN · Homo sapiens
As of 2026-09-12
ChEMBL target ID
CHEMBL1163125
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-12
www.ebi.ac.uk
UniProt accession
O60885
Bromodomain-containing protein 4
UniProt accession via ChEMBL component mapping As of 2026-09-12
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-12
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Bromodomain-containing protein 4 is the right protein anchor across sources, using UniProt O60885 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBromodomain-containing protein 4
UniProt AccessionO60885
Component TypeProtein
Sequence Length1362 aa

Bromodomain-containing protein 4

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Bromodomain-containing protein 4, mapped to UniProt O60885. Sequence length is 1362 aa.

Mapped IDO60885
Review nameBromodomain-containing protein 4
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

11
Approved
9
Phase III
21
Phase II
11
Phase I
Assay Mix

Activity Type Distribution

IC5019,000.0
KI3,410.0
EC50171.0
KD891.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5170488 10.02 Kd 0.095 Preclinical
CHEMBL4648912 10.0 Kd 0.1 Preclinical
CHEMBL5424952 10.0 IC50 0.1 Preclinical
CHEMBL5440537 9.7 IC50 0.2 Preclinical
CHEMBL5432745 9.7 IC50 0.2 Preclinical
CHEMBL3895096 9.62 IC50 0.24 Preclinical
CHEMBL3898684 9.6 Ki 0.25 Preclinical
CHEMBL5914594 9.52 IC50 0.3 Preclinical
CHEMBL5440963 9.52 IC50 0.3 Preclinical
CHEMBL5401253 9.52 IC50 0.3 Preclinical
Distribution

pChEMBL Value Distribution

1576
5.0
1537
5.5
2274
6.0
2111
6.5
2465
7.0
1940
7.5
1152
8.0
713
8.5
276
9.0
15
9.5
pChEMBL
Approved Drugs

Approved Drugs

FEDRATINIB
CHEMBL1287853
Approved 2019
PANOBINOSTAT
CHEMBL483254
Approved 2015
BELINOSTAT
CHEMBL408513
Approved 2014
ROMIDEPSIN
CHEMBL343448
Approved 2009
VORINOSTAT
CHEMBL98
Approved 2006
NORFLOXACIN
CHEMBL9
Approved 1986
Assay Landscape

Assay Landscape

3,563
Total Assays
9,733
Tested Compounds
3
Assay Types
Binding — 3,541 assays, 9,733 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2,063 817 6.8
single protein format 1,131 7,566 6.6
assay format 338 1,290 6.5
subcellular format 5 1 8.2
organism-based format 2 25 5.9
tissue-based format 2 34 6.5
Functional — 18 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 12 2 6.9
assay format 4 3 8.4
tissue-based format 2 1 5.9
ADME — 4 assays, 53 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 52 4.6
assay format 1 1 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine